# Krintafel

NDC: 0173-0889
Generic name: tafenoquine succinate
Labeler / Manufacturer: GlaxoSmithKline LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190122

FDA application: NDA210795

## Active ingredients

- TAFENOQUINE SUCCINATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0173-0889"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0889
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cf989d5-36f5-4561-a30b-9fcb9deb6b6a